Kotler Kevin’s Takeda Pharmaceutical TAK Stock Holding History

Kotler Kevin’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$312K	Buy	+20,000	New	+$286K	0.07%	32

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Kotler Kevin's TAK Position: Q4 2025 in Review

Kotler Kevin opened a new position in Takeda Pharmaceutical (TAK) in Q4 2025: 20,000 shares worth $312K. The stake represents 0.07% of the portfolio and ranks #32 among its holdings.

349 funds tracked by Wall St. Rank hold TAK as of Q4 2025.

Kotler Kevin held 20,000 shares of Takeda Pharmaceutical worth $312K as of Q4 2025.
Takeda Pharmaceutical was a new Kotler Kevin position in Q4 2025.
Takeda Pharmaceutical made up 0.07% of Kotler Kevin's portfolio in Q4 2025, its #32 holding.
349 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2025.

Based on Kotler Kevin's 13F filing for Q4 2025, filed 17 Feb 2026.